Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 28, 2019 - Issue 6
Submit an article Journal homepage
1,495
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Novel drug therapies for cardiac amyloidosis

Prakash HarikrishnanDivsion of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USAView further author information
,
Srikanth YandrapalliDivsion of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USAView further author information
,
Wilbert S. AronowDivsion of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USACorrespondence[email protected]
View further author information
,
Gregg M. LanierDivsion of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USAView further author information
&
Diwakar JainDivsion of Cardiology, Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY, USAView further author information
Pages 497-499 | Received 04 Mar 2019, Accepted 13 May 2019, Published online: 21 May 2019

References

  • Banypersad SM, Moon JC, Whelan C, et al. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012;1(2):e000364.
  • Ng B, Connors LH, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005;165(12):1425–1429.
  • Bokhari S, Castaño A, Pozniakoff T, et al. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6(2):195–201.
  • Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488–497.
  • Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.
  • Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016.
  • Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2006;13(4):236–249.
  • Koyama J, Minamisawa M, Sekijima Y, et al. Left ventricular deformation and torsion assessed by speckle-tracking echocardiography in patients with mutated transthyretin-associated cardiac amyloidosis and the effect of diflunisal on myocardial function. Int J Cardiol Heart Vasc. 2015;9:1–10.
  • Sekijima Y, Tojo K, Morita H, et al. Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2015;22(2):79–83.
  • Adams D, Gonzalez-Duarte A, O’Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11–21.
  • Benson MD, Waddington-Cruz M, Berk JL, et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):22–31.
  • Gertz MA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol. 2013;88(5):416–425.
  • Dorbala S, Vangala D, Semer J, et al. Imaging cardiac amyloidosis: a pilot study using (18)F florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652–1662.
  • Law WP, Wang WY, Moore PT, et al. Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. J Nucl Med. 2016;57:1733–1739.
  • Butler JS, Chan A, Costelha S, et al. Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis. Amyloid. 2016 Jun;23(2):109–118.
  • [cited 2019 Apr 30]. Availabe from: https://clinicaltrials.gov/ct2/show/NCT03702829
  • [cited 2019 Apr 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT03860935
  • Daria A, Colombo A, Llovera G, et al. Young microglia restore amyloid plaque clearance of aged microglia. Embo J. 2017;36(5):583–603.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.